Novo Nordisk, the Denmark-based diabetes drug producer, is planning to commence clinical trials for Aerx, an insulin inhaler, in India. Anil Kapur, managing director of Novo Dordisk India, said:
Novo Nordisk Lines Up Trials Of Insulin Inhaler Aerx
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Dec 04 2002 | 12:00 AM IST
